NetWorth
LeaderPortfolio
Ramaswamy
Vivek Ramaswamy
Rank #1737
UNITED STATES•Finance Investments•investments

Vivek Ramaswamy

Net Worth
$2.358B
-2.02% (24h)
Vivek Ramaswamy is an American entrepreneur, author, and political activist. Born in Cincinnati, Ohio, in 1985, Ramaswamy is best known for founding Roivant Sciences in 2014, a biotechnology company focused on drug development, and for his subsequent political career. He gained prominence for his outspoken views on corporate governance, social issues, and environmental, social, and governance (ESG) investing, leading him to author the book "Woke, Inc." His career has been marked by a blend of academic achievements, business ventures, and political engagement, including a bid for the 2024 Republican presidential nomination. Ramaswamy's source of wealth is primarily from investments, and his estimated net worth is $1.3 billion.

How to read Vivek Ramaswamy's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Vivek Ramaswamy, we anchor the narrative to Investments and investments, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $2.358B alongside global rank #1737, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (UNITED STATES) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life and Education

Vivek Ganapathy Ramaswamy was born on August 9, 1985, in Cincinnati, Ohio, to Indian immigrant parents. He attended St. Xavier High School, graduating as valedictorian. Ramaswamy graduated summa cum laude from Harvard University in 2007 with a bachelor's degree in biology. He later earned a Juris Doctor from Yale Law School in 2013. During his time at Harvard, he was involved in various activities, including serving as president of the Harvard Political Union.

Rise to Success

After graduating from Harvard, Ramaswamy worked at a hedge fund before founding Roivant Sciences in 2014. Roivant Sciences aimed to improve healthcare by accelerating the delivery of novel therapies. The company's strategy involved acquiring and developing drug candidates. He also co-founded Strive Asset Management in 2022, challenging ESG trends.

Key Business Strategies

Ramaswamy's primary business strategy revolved around Roivant Sciences and its unique "Vant" model, which created specialized subsidiaries for focused drug development. This approach allowed for the focused development and efficient operations of various drug candidates. Through this strategy, he expanded his investments to include the development of early-stage drug candidates and technology platforms. In 2023, Ramaswamy's personal income from his business ventures was at least $250 million.

Philanthropy

Information regarding the exact amount of Vivek Ramaswamy's philanthropy is not available in the search results.

Career Timeline

2022

Co-founded Strive Asset Management

Co-founded Strive Asset Management, an investment firm.

2014

Founded Roivant Sciences

Founded the biotechnology firm Roivant Sciences.

2007

Co-founded Campus Venture Network

Co-founded Campus Venture Network, a private social networking website for university students.

Philanthropic Impact

Unknown$XB

Not Available

Information regarding the exact amount of Vivek Ramaswamy's philanthropy is not available in the search results.

Key Business Ventures & Holdings

CompanyStakeValue
Roivant Sciences10.50%$1.3M

Net Worth History

In-Depth Analysis

Early Life and Education

Vivek Ganapathy Ramaswamy was born on August 9, 1985, in Cincinnati, Ohio, to Indian immigrant parents. He attended St. Xavier High School, graduating as valedictorian. Ramaswamy graduated summa cum laude from Harvard University in 2007 with a bachelor's degree in biology. He later earned a Juris Doctor from Yale Law School in 2013. During his time at Harvard, he was involved in various activities, including serving as president of the Harvard Political Union.

Rise to Success

After graduating from Harvard, Ramaswamy worked at a hedge fund before founding Roivant Sciences in 2014. Roivant Sciences aimed to improve healthcare by accelerating the delivery of novel therapies. The company's strategy involved acquiring and developing drug candidates. He also co-founded Strive Asset Management in 2022, challenging ESG trends.

Key Business Strategies

Ramaswamy's primary business strategy revolved around Roivant Sciences and its unique "Vant" model, which created specialized subsidiaries for focused drug development. This approach allowed for the focused development and efficient operations of various drug candidates. Through this strategy, he expanded his investments to include the development of early-stage drug candidates and technology platforms. In 2023, Ramaswamy's personal income from his business ventures was at least $250 million.

Philanthropy

Information regarding the exact amount of Vivek Ramaswamy's philanthropy is not available in the search results.

Data Sources & Methodology

Figures for Vivek Ramaswamy are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.

You may also like

HubAll BillionairesHubGlobal RankingsHubNewsroom